Shrikant Mishra Professor, and Head, Technology and Translation Laboratory, Kiit School Of Biotechnology is a student of science, with 32 years of experience in biotechnology, with 12 biotechnology derived products in regulatory filing, 7 products delivered post Phase III human trials to the clinic, with 23 patents, 32 international publications, and having three life saving products in ICU.
After completing BSc. and MSc. From St. Stephen’s College, Delhi University, New Delhi, India, he pursued his doctoral studies in Biochemistry at Virginia Maryland Regional College Of Veterinary Medicine, Virginia Tech, USA on TNF cytotoxicity pathway. For the post doctoral work, he worked on role of free radicals in preeclampsia (Virginia Tech), protein protein interaction in EGFR, erbB2 and cdc20 signalling (University of Maryland), cloning of putative tumor suppressor psedugene CLP and antisense in breast cancer cells (Mayo Clinic).
He returned to India in 1995 and set up to head 120 scientists and associates at Biotechnology Research laboratory (BRL) USV Ltd, Mumbai to make biotechnology derived generic recombinants including hGH, PDGF-BB, Neseritide, PTH(1-34), rEK, G-CSF, PEG-G-CSF, Lucentis, and Fmoc chemistry derived modelled peptides (eptifibatide, bivalirudine, octreotide).
He is trained in molecular biology / organic chemistry /biophysics multitasking led technology development and troubleshooting for biotech drugs. He has helped various companies like Sun Pharma, Intas Biopharma, and USV, in the development of biotechnology derived products.
At present he is Head Of Technology & Translational Research Laboratory and teaches MSc Final Year and MTech Biotechnology students. He anchors students for their Xth Semester Thesis. He imparts summer training for pharma students’ hands on training including in DSC, TGA, CHNSO, ICP-MS, LC-MS/MS, and NMR etc.
He trains about 170 MTech students every year in biotechnology derived processes and analytics including cell culture techniques, stem cell culture, flow cytometry, cloning in E coli and mammalian hosts.
He is the founder of a Startup called “Royal Bio International Pvt Ltd. He is Chief Scientific Advisor to E.O. Bio Pvt ltd for Genome Editing of immune cells for amelioration of solid tumors.